Global Constipation Treatment Market Size 2024, Forecast To 2033
8 Mar, 2024
The constipation treatment market has experienced strong growth, rising from $10.95 billion in 2023 to $11.65 billion in 2024, with a compound annual growth rate (CAGR) of 6.4%. This growth is driven by factors such as the rising prevalence of digestive disorders and increasing awareness of health issues. Forecasts suggest continued strong growth, with the market expected to reach $15.09 billion by 2028, growing at a CAGR of 6.7%. This growth is attributed to trends such as the rising healthcare expenditure and the focus on pediatric constipation. Major trends in the forecast period include technological advancements in healthcare and the rise of telemedicine, as well as increased investment in research and development by pharmaceutical companie
Global Constipation Treatment Market Key Driver
Growing consumption of fast food, reflected in statistics on the global fast food market, is propelling the growth of the constipation treatment market. Fast food, known for its low fiber content and high fat and salt content, contributes to digestive issues like constipation, driving demand for treatment options. With the fast food market projected to reach $931.7 billion by 2027, the constipation treatment market is expected to grow in tandem with increasing fast food consumption trends.
Get A Free Sample Of The Global Constipation Treatment Market ReportGlobal Constipation Treatment Market Segments
The constipation treatment market covered in this report is segmented –
1) Therapeutic Types:Laxatives, Chloride Channel Activators, Peripherally Acting Mu-Opioid Receptor Antagonists, GC-C (Guanylate Cyclase-C) Agonists, Other Therapeutics
2) Disease Type:Chronic Idiopathic Constipation (CIC), Irritable Bowel Syndrome With Constipation (IBS-C), Opioid-Induced Constipation (OIC)
3) Distribution Channel:Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
By Geography: The countries covered in the constipation treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
North America was the largest region in the constipation treatment market in 2023. North America is expected to be the fastest-growing region in the forecast period. The regions covered in the constipation treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Major Constipation Treatment Industry Players
Pfizer Inc.; Johnson & Johnson; AbbVie Inc.; Bayer AG; Novartis AG; Merck & Co. Inc.; Sanofi S.A.; AstraZeneca plc; Fresenius Kabi AG; GlaxoSmithKline plc; Takeda Pharmaceutical Company Ltd.; Boehringer Ingelheim International GmbH; Regeneron Pharmaceuticals; Bausch Health Companies Inc.; Eisai Co. Ltd.; Shionogi & Co. Ltd.; Mallinckrodt Plc; Salix Pharmaceuticals Inc.; Prestige Consumer Healthcare Inc.; Taiho Pharmaceutical Co. Ltd.; Ironwood Pharmaceuticals Inc.; Cosmo Pharmaceuticals NV; Ferring Pharmaceuticals; RedHill Biopharma Ltd.; Probi AB; 4D Pharma plc
Get The Full Global Constipation Treatment Market Report
Constipation Treatment Market Overview
Constipation treatment refers to the numerous methods and measures taken to alleviate and manage the ailment, which is characterized by irregular or difficult bowel motions and frequently hard or dry stools. It is used to examine the rectum and lower, or sigmoid, colon and to treat constipation.